AMGEN INC — Director's Dealing 2012

Feb 7, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMGEN INC (AMGN)
CIK: 0000318154
Period of Report: 2012-02-07

Reporting Person: BEIER DAVID W (SVP, Global Govt Affairs)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-02-07	Common Stock	M	10000	$50.44	Acquired	41902	Direct
2012-02-07	Common Stock	M	10000	$58.43	Acquired	51902	Direct
2012-02-07	Common Stock	S	20000	$68.8839	Disposed	31902	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-02-07	Nqso (Right to Buy)	$50.44	M	10000	Disposed	2016-04-28	Common Stock (10000)	Direct
2012-02-07	Nqso (Right to Buy)	$58.43	M	10000	Disposed	2020-04-26	Common Stock (10000)	Direct

Footnotes

F1: The price reported is an average price. The prices ranged from $68.84 to $68.91 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer.

F2: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 2,850 RSUs which fully vest on 4/29/2012; 2,850 RSUs which vest in two equal annual installments of 1,425 each commencing 4/28/2012; 4,350 RSUs which vest in three equal annual installments of 1,450 each commencing 4/26/2012; and 7,500 RSUs which vest in two equal installments of 2,475 each on 4/25/2013 and 4/25/2014 and one installment of 2,550 on 4/25/2015. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.